Fresenius Group is a global healthcare company with annual revenue of €21.5 billion, headquartered in Bad Homburg vor der Höhe, Germany. The group operates across three core therapy platforms: (Bio)Pharma including clinical nutrition, MedTech, and Care Provision, serving critically and chronically ill patients worldwide through approximately 176,000 employees.
The company's portfolio includes Fresenius Kabi, which produces pharmaceuticals and clinical nutrition products for hospital and home care settings; Fresenius Helios, Europe's leading private hospital operator; and Fresenius Medical Care, the world's leading provider of dialysis products and services serving approximately 4.5 million patients globally. These divisions position Fresenius across the full spectrum of healthcare delivery, from pharmaceutical manufacturing to clinical care provision.
Fresenius operates in Europe, the Americas, and other global markets. The group's strategic direction, outlined in its #FutureFresenius program, emphasises positioning for continuous growth within the evolving healthcare landscape while maintaining its focus on affordable, accessible, and innovative healthcare solutions.
